User login
Register today for the fourth annual AGA Tech Summit, which will be held March 15-16, 2013, at the Four Seasons Hotel Silicon Valley in East Palo Alto, Calif.
The summit addresses critical elements that affect the likelihood of success in developing and obtaining adoption and coverage of new medical technologies in today’s GI market. Sessions explore the latest developments in reimbursement, the regulatory and legal environment, intellectual property, and more. You will hear directly from the Food and Drug Administration, private payers, and medical device executives, who will address specific requirements. Areas of unmet need and clinical and research opportunities will be discussed in areas such as the intestinal microbiome, inflammatory bowel disease, pancreatitis, and the liver.
You will also learn about what the AGA is doing to help create a more supportive environment for new technologies, like the AGA Technology Center and AGA initiatives that support innovation in digestive and metabolic diseases.
A new addition to the program, the physician innovator track, offers GI MD inventors beneficial information on how to obtain funding for their idea. This specialized track also gives insight on what investors are looking for, how to protect intellectual property, and how physician-investors can be successful in academic, private practice, or industry settings.
To register and view the program, visit www.gastro.org/tech-summit.
The AGA Institute and Kleiner Perkins Caufield & Byers gratefully acknowledge our corporate sponsors.
medical technologies, reimbursement, regulatory, legal environment, intellectual property, the Food and Drug Administration, private payers, medical device executives, requirements, clinical, research, intestinal microbiome, inflammatory bowel disease, pancreatitis, liver.
Register today for the fourth annual AGA Tech Summit, which will be held March 15-16, 2013, at the Four Seasons Hotel Silicon Valley in East Palo Alto, Calif.
The summit addresses critical elements that affect the likelihood of success in developing and obtaining adoption and coverage of new medical technologies in today’s GI market. Sessions explore the latest developments in reimbursement, the regulatory and legal environment, intellectual property, and more. You will hear directly from the Food and Drug Administration, private payers, and medical device executives, who will address specific requirements. Areas of unmet need and clinical and research opportunities will be discussed in areas such as the intestinal microbiome, inflammatory bowel disease, pancreatitis, and the liver.
You will also learn about what the AGA is doing to help create a more supportive environment for new technologies, like the AGA Technology Center and AGA initiatives that support innovation in digestive and metabolic diseases.
A new addition to the program, the physician innovator track, offers GI MD inventors beneficial information on how to obtain funding for their idea. This specialized track also gives insight on what investors are looking for, how to protect intellectual property, and how physician-investors can be successful in academic, private practice, or industry settings.
To register and view the program, visit www.gastro.org/tech-summit.
The AGA Institute and Kleiner Perkins Caufield & Byers gratefully acknowledge our corporate sponsors.
Register today for the fourth annual AGA Tech Summit, which will be held March 15-16, 2013, at the Four Seasons Hotel Silicon Valley in East Palo Alto, Calif.
The summit addresses critical elements that affect the likelihood of success in developing and obtaining adoption and coverage of new medical technologies in today’s GI market. Sessions explore the latest developments in reimbursement, the regulatory and legal environment, intellectual property, and more. You will hear directly from the Food and Drug Administration, private payers, and medical device executives, who will address specific requirements. Areas of unmet need and clinical and research opportunities will be discussed in areas such as the intestinal microbiome, inflammatory bowel disease, pancreatitis, and the liver.
You will also learn about what the AGA is doing to help create a more supportive environment for new technologies, like the AGA Technology Center and AGA initiatives that support innovation in digestive and metabolic diseases.
A new addition to the program, the physician innovator track, offers GI MD inventors beneficial information on how to obtain funding for their idea. This specialized track also gives insight on what investors are looking for, how to protect intellectual property, and how physician-investors can be successful in academic, private practice, or industry settings.
To register and view the program, visit www.gastro.org/tech-summit.
The AGA Institute and Kleiner Perkins Caufield & Byers gratefully acknowledge our corporate sponsors.
medical technologies, reimbursement, regulatory, legal environment, intellectual property, the Food and Drug Administration, private payers, medical device executives, requirements, clinical, research, intestinal microbiome, inflammatory bowel disease, pancreatitis, liver.
medical technologies, reimbursement, regulatory, legal environment, intellectual property, the Food and Drug Administration, private payers, medical device executives, requirements, clinical, research, intestinal microbiome, inflammatory bowel disease, pancreatitis, liver.